financetom
Business
financetom
/
Business
/
Europe should activate countermeasures against Trump tariffs, lawmaker says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Europe should activate countermeasures against Trump tariffs, lawmaker says
Jul 12, 2025 12:32 PM

BERLIN (Reuters) -A senior European lawmaker said on Saturday Brussels should react immediately with countermeasures against U.S. President Donald Trump's "outrageous" threat to hike tariffs on imports from the European Union.

The EU had been negotiating intensively with Washington for more than three weeks and had made concessions, said Bernd Lange, the head of the European Parliament's trade committee.

The bloc had also suspended all countermeasures after the U.S. imposed an initial tariff of 20% on European imports in April.

"It is brazen and disrespectful to increase the tariffs on European goods announced on April 2 from 20% to 30%," Lange told Reuters.

"This is a slap in the face for the negotiations. This is no way to deal with a key trading partner," he added.

Europe should make it clear that these "unfair trade practices" were unacceptable, Lange said.

"We have postponed the first stage of our countermeasures for the time being, but I am firmly convinced that they must now be implemented immediately," he said.

"The first list of countermeasures must be activated on Monday as planned, and the second list should also follow quickly."

(Reporting by Andreas Rinke, writing by John Revill, editing by Thomas Seythal)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Canadian Dollar Pops on Premier's Resignation But Bank of Canada Has Long Easing Road Ahead, Says Rosenberg Research
Canadian Dollar Pops on Premier's Resignation But Bank of Canada Has Long Easing Road Ahead, Says Rosenberg Research
Jan 7, 2025
08:04 AM EST, 01/07/2025 (MT Newswires) -- While the Canadian dollar (CAD or loonie) received a lift from Prime Minister Justin Trudeau's resignation on Monday, the big drop in the country's composite PMI to 49.0 in December from 51.5 in November -- services contracting to 48.2 from 51.2 -- serves as a reminder that the Bank of Canada has more...
Canada Nickel Secures Surface Rights for Crawford Nickel Project
Canada Nickel Secures Surface Rights for Crawford Nickel Project
Jan 7, 2025
08:05 AM EST, 01/07/2025 (MT Newswires) -- Canada Nickel ( CNIKF ) on Tuesday said it has signed a definitive agreement with the primary surface rights holder in Crawford and surrounding townships n Ontario for 32,000 acres of surface rights to build the Crawford Nickel Sulphide project. In return, the company will issue 5.5 million shares and transfer 47,750 acres...
Cerro de Pasco Resources Provides Assays From Quiulacocha Project in Peru
Cerro de Pasco Resources Provides Assays From Quiulacocha Project in Peru
Jan 7, 2025
08:04 AM EST, 01/07/2025 (MT Newswires) -- Cerro de Pasco Resources ( GPPRF ) reported Tuesday assays for an additional eight drill holes from the Quiulacocha tailings project in Peru. Highlights include 31 meters at 47 grams per tonne (g/t) silver, 1.30% zinc, 0.87% lead, and 58 g/t gallium. The consistent and increasing presence of gallium, a critical metal essential...
J&J's combo extends patients' lives in head-to-head study with AstraZeneca's drug
J&J's combo extends patients' lives in head-to-head study with AstraZeneca's drug
Jan 7, 2025
By Bhanvi Satija Jan 7 (Reuters) - Johnson & Johnson ( JNJ ) said on Tuesday its chemotherapy-free combination treatment showed a meaningful improvement in extending lives of patients with a type of lung cancer, compared to AstraZeneca's ( AZN ) blockbuster drug Tagrisso. The combination of J&J's cancer drugs Rybrevant and lazertinib, approved in August for previously untreated non-small...
Copyright 2023-2026 - www.financetom.com All Rights Reserved